Under construction – not a live service
Sign in
Taking people in FranceNo phase

Ablative Technique For Ovarian Preservation In Endometrioma

Key facts

Where
Bordeaux, FranceSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 43 years old?

Source: NCT07119060, who can take part

Where in France

  • IFEMEndo - Clinique TivoliBordeaux, FranceTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Clinique Tivoli Ducos
Trial code
NCT07119060
Record updated
19 March 2026
Original description
The goal of this clinical trial is to compare pregnancy rates after different surgical treatments for endometriomas in adult women who have one or more ovarian cysts (endometriomas) larger than 2 cm requiring surgery. The main questions it aims to answer are:Read full original descriptionShow less

Monocentric, Controlled, Randomized Trial: Comparison of Pregnancy Rates in Women With One or More Endometriomas, Treated by Cystectomy, Plasma Vaporization, or Sclerotherapy

The goal of this clinical trial is to compare pregnancy rates after different surgical treatments for endometriomas in adult women who have one or more ovarian cysts (endometriomas) larger than 2 cm requiring surgery. The main questions it aims to answer are:

How many women become pregnant within 24 months after surgery ? What are the birth rates and different types of pregnancies (natural, with fertility treatments, and those continuing beyond 12 weeks)? How often do the endometriomas come back after surgery? What surgery-related complications occur? How do pain levels change after treatment?

Researchers will compare different surgical treatment groups to see if one approach results in better pregnancy outcomes and fewer complications.

Participants will:

Be randomly assigned to different surgical treatment groups Undergo surgery for their endometriomas and endometriosis Attend follow-up visits at 3 months and 24 months after the procedure Have their pregnancy outcomes, pain levels, and potential complications monitored throughout the study period

Inclusion: Patient aged between 18 and 43 years (inclusive); Patient diagnosed with endometriosis (by histology or imaging) and symptomatic, requiring surgery (pelvic pain and/or infertility and/or risk to an organ); Pelvic MRI or ultrasound performed within the last year showing at least one endometrioma larger than 20 mm in diameter; Patient with an intention to conceive (probable or certain) after surgery; Patient informed and having signed the consent form; Patient covered by a social security scheme.

Exclusion: Intraoperative finding that the cyst is not an endometrioma; Patient under guardianship, conservatorship, or incapable of giving consent; Patient without sufficient understanding of the French language; Patient under judicial protection measures; Patient who is pregnant or breastfeeding.

ClinicalTrials.gov NCT07119060